Michael Kauffman, Chief Executive Officer at Karyopharm Therapeutics Inc. (KPTI), sold 14,643 shares at $16.38 ($240K) on 2020-06-15, disclosed to the SEC on 2020-06-17.
Open-market sale of $240k KPTI by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.20 | 357 | $6K | 2.4% |
| 2 | $16.38 | 7,143 | $117K | 48.8% |
| 3 | $16.38 | 7,143 | $117K | 48.8% |
| Total | $16.38 avg | 14,643 | $240K | 100% |
| Filing → |
| KPTI | SELL | 2022-03-02 | $128K | — | Filing → |
| KPTI | SELL | 2022-02-22 | $440K | — | Filing → |
| KPTI | SELL | 2022-02-09 | $266K | — | Filing → |